73428-17-8 ([3,8'-双-4H-1-苯并吡喃]-4,4'-二酮,2,2'-双(3,4-二羟基苯基)-2,2',3,3'-四氢-3',5,5',7,7'-五羟基-(2S,2'R,3R,3'R)-,[3,8'-Bi-4H-1-benzopyran]-4,4'-dione,2,2'-bis(3,4-dihydroxyphenyl)-2,2',3,3'-tetrahydro-3',5,5',7,7'-pentahydroxy-,(2S,2'R,3R,3'R)-)

CAS号:
73428-17-8
中文名称:
[3,8'-双-4H-1-苯并吡喃]-4,4'-二酮,2,2'-双(3,4-二羟基苯基)-2,2',3,3'-四氢-3',5,5',7,7'-五羟基-(2S,2'R,3R,3'R)-
英文名称:
[3,8'-Bi-4H-1-benzopyran]-4,4'-dione,2,2'-bis(3,4-dihydroxyphenyl)-2,2',3,3'-tetrahydro-3',5,5',7,7'-pentahydroxy-,(2S,2'R,3R,3'R)-
分子式:
C30H22O13
分子量:
590.487889766693
植物源:

[3,8'-双-4H-1-苯并吡喃]-4,4'-二酮,2,2'-双(3,4-二羟基苯基)-2,2',3,3'-四氢-3',5,5',7,7'-五羟基-(2S,2'R,3R,3'R)-(73428-17-8)名称与标识符

名称

英文别名:
[3,8'-Bi-4H-1-benzopyran]-4,4'-dione,2,2'-bis(3,4-dihydroxyphenyl)-2,2',3,3'-tetrahydro-3',5,5',7,7'-pentahydroxy-,(2S,2'R,3R,3'R)-;(2R,3R)-2-(3,4-dihydroxyphenyl)-8-[(2S,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-2,3-dihydrochromen-3-yl]-3,5,7-trihydroxy-2,3-dihydrochromen-4-one;[2S-[2alpha,3beta(2'S*,3'S*)]]-2,2'-bis(3,4-dihydroxyphenyl)-2,2',3,3'-tetrahydro-3',5,5',7,7'-pentahydroxy[3,8'-bi-4H-1-benzopyran]-4,4'-dione;[3,8'-Bi-4H-1-benzopyran]-4,4'-dione,2,2'-bis(3,4-dihydroxyphenyl)-2,2',3,3'-tetrahydro-3',5,5',7,7'-pentahydroxy-,(2S,2'R,3R;(2S-(2alpha,3beta(2'S*,3'S*)))-2,2'-Bis(3,4-dihydroxyphenyl)-2,2',3,3'-tetrahydro-3',5,5',7,7'-pentahydroxy(3,8'-bi-4H-1-benzopyran)-4,4'-dione;(2S,2'R,3R,3'R)-2,2'-bis(3,4-dihydroxyphenyl)-3',5,5',7,7'-pentahydroxy-2,2',3,3'-tetrahydro-4H,4'H-3,8'-bichromene-4,4'-dione;(3,8'-Bi-4H-1-benzopyran)-4,4'-dione, 2,2',3,3'-tetrahydro-2,2'-bis(3,4-dihydroxyphenyl)-3',5,5',7,7'-pentahydroxy-, (2S-(2-alpha,3-beta(2'S*,3'S*)))-;Manniflavanone;EINECS 277-471-6;73428-17-8;SCHEMBL4742855;DTXSID20223658;NS00037517;LMPK12040007;C09763;Garciniflavanone;(2R,3S,2''R,3''R)-Manniflavanone;

标识符

InChIKey:
UKRJEVDCOVVSAB-BENTYHEHSA-N
Inchi:
1S/C30H22O13/c31-12-7-17(36)21-20(8-12)42-28(10-1-3-13(32)15(34)5-10)24(25(21)39)22-18(37)9-19(38)23-26(40)27(41)29(43-30(22)23)11-2-4-14(33)16(35)6-11/h1-9,24,27-29,31-38,41H/t24-,27-,28+,29+/m0/s1
SMILES:
O1C2C=C(C=C(C=2C([C@H](C2=C(C=C(C3C([C@@H]([C@@H](C4C=CC(=C(C=4)O)O)OC2=3)O)=O)O)O)[C@H]1C1C=CC(=C(C=1)O)O)=O)O)O

[3,8'-双-4H-1-苯并吡喃]-4,4'-二酮,2,2'-双(3,4-二羟基苯基)-2,2',3,3'-四氢-3',5,5',7,7'-五羟基-(2S,2'R,3R,3'R)-(73428-17-8)物化性质

计算特性

  • 精确分子量 : 590.10604075g/mol
  • 氢键供体数量 : 9
  • 氢键受体数量 : 13
  • 可旋转化学键数量 : 3
  • 同位素质量 : 590.10604075g/mol
  • 重原子数量 : 43
  • 复杂度 : 1040
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 4
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.3
  • 拓扑分子极性表面积 : 235Ų